Explore features and points of view
from Novo Nordisk Canada and the society we serve
Sunday, April 21, 2019 was World Creativity and Innovation Day (#WCID).
Read the story
In Canada, about 3,100 people live with hemophilia. While rare, this bleeding disorder can have serious health impacts: chronic pain, limited mobility and even risk of premature death if treated inadequately.
I was speaking to a friend recently about a perception many have of pharmaceutical companies, and the impact of this industry on society.
Patient-centricity is the mindset of designing a service or solution around a patient.
Novo Nordisk is collaborating with cross-sector partners at the intersection of diabetes and food insecurity to support healthier options for the most vulnerable populations.
The story of insulin is one of collaboration—its discovery, development and continued innovation made possible by a common goal of changing diabetes.
Today marks the third annual World Obesity Day. By 2025, it is estimated that 2.7 billion people will be overweight or living with obesity.
As the leader of a Canadian company focused on improving the health of Canadians, supporting individuals in their pursuit of healthy living continues to be a big source of motivation.
Novo Nordisk was born out of a mission to truly put patients first, supporting the 382 million people around the world living with diabetes.*
We believe that having a workplace grounded in strong values helps to attract the right people to our team. We also believe that our team draws inspiration from the spaces they work in every day.
What makes up a large part of the person you are today comes from your roots. From where you grew up, to what sparked your interests in life.